Equities

HUTCHMED (China) Ltd

HCM:LSE

HUTCHMED (China) Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)214.00
  • Today's Change-4.00 / -1.83%
  • Shares traded5.07k
  • 1 Year change-5.52%
  • Beta1.2595
Data delayed at least 20 minutes, as of Feb 06 2026 16:28 GMT.
More ▼

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
OPERATIONS
Net income38101(360)
Depreciation/depletion128.218.66
Non-Cash items(23)(4.54)(17)
Cash taxes paid, supplemental3.593.7319
Cash interest paid, supplemental2.510.420.15
Changes in working capital(27)114100
Total cash from operations0.50219(269)
INVESTING
Capital expenditures(18)(33)(37)
Other investing and cash flow items, total(78)(259)333
Total cash from investing(96)(291)297
FINANCING
Financing cash flow items(1)(9.07)(26)
Total cash dividends paid------
Issuance (retirement) of stock, net(35)(3.98)(48)
Issuance (retirement) of debt, net5.6162(9.17)
Total cash from financing(31)49(83)
NET CHANGE IN CASH
Foreign exchange effects(3.4)(6.47)(9.49)
Net change in cash(130)(30)(64)
Net cash-begin balance/reserved for future use284313378
Net cash-end balance/reserved for future use154284313
SUPPLEMENTAL INCOME
Depreciation, supplemental128.218.66
Cash interest paid, supplemental2.510.420.15
Cash taxes paid, supplemental3.593.7319
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.